Huberman LabUnderstanding & Healing the Mind | Dr. Karl Deisseroth
CHAPTERS
- 0:00 – 30:00
Introduction: Why Deisseroth and Why This Conversation
Andrew Huberman introduces Dr. Karl Deisseroth as the first guest of the Huberman Lab podcast, outlining his dual role as psychiatrist and pioneering neuroscientist. He previews the themes: optogenetics, psychiatric disorders like depression and autism, psychedelic therapies, consciousness, and how Deisseroth manages an immense professional and personal workload. The segment also includes sponsor messages before the core discussion begins.
- •Deisseroth’s clinical work spans OCD, autism, ADHD, schizophrenia, mania, anxiety, and eating disorders.
- •His lab pioneered channelrhodopsins for light-based control of neurons, a foundational technology in optogenetics.
- •Channelrhodopsins have already restored partial vision in a blind human patient.
- •Deisseroth’s book *Projections: A Story of Human Emotions* uses patient stories to explain brain function and the development of new tools.
- •Huberman frames this episode as a deep dive into healthy vs. diseased brain function, psychedelics, consciousness, and work–life organization.
- 30:00 – 46:00
Neurology vs. Psychiatry and the Problem of Measuring Feelings
Deisseroth distinguishes neurology from psychiatry, emphasizing that neurology has visible lesions and tests, whereas psychiatry lacks objective physical markers. They explore how psychiatry is constrained by language, the difficulty of relying on patients’ words, and how clinicians parse real symptoms from colloquial labels like “depressed.” They also touch on comorbidities like Parkinson’s with depression, and whether we might eventually have quantitative tests for mental disorders.
- •Neurologists rely on scans and EEGs to see strokes and seizures; psychiatrists lack equivalent biomarkers.
- •Psychiatry works with invisible brain circuit dysfunctions inferred through words and behavior.
- •Patient verbosity can help, but reduced speech itself can be a symptom (depression, negative symptoms, autism).
- •Depression frequently co-occurs with Parkinson’s, likely due to loss of midbrain dopamine neurons; ALS does not show the same pattern.
- •Deisseroth expects future quantitative markers (e.g., EEG rhythm ratios, behavioral metrics), but stresses ethical concerns around data collection.
- •Stigma remains a major barrier; untreated anxiety can evolve into depression when people delay seeking help.
- 46:00 – 1:00:00
Diagnosing Emotions, Baselines, and Early Warning Signs
The conversation turns to how psychiatrists get beyond vague labels to specific, operationalizable features of mood and motivation. Deisseroth explains how questions about hope, planning, sleep, and appetite map to diagnostic constructs like hopelessness or vegetative signs. They discuss the value and challenges of objective body-based measures (sleep logs, movement, voice changes) and how subtle behavioral shifts can signal approaching depressive episodes before patients notice.
- •Psychiatrists translate vague complaints into precise, real-world indicators (e.g., inability to plan tomorrow = hopelessness).
- •Vegetative signs—sleep and appetite changes, psychomotor agitation or slowing—are core to diagnosing depression but vary per person.
- •Individual baselines are crucial; without knowing someone’s “normal,” it’s hard to interpret deviations.
- •Ethical and privacy considerations complicate continuous baseline data collection, even though phones/accelerometers make it technically possible.
- •Family members and early-morning awakenings (2–5 a.m. wakeups with inability to return to sleep) can provide early-warning signs of an oncoming depressive episode.
- •Technology may eventually provide personal alerts (e.g., voice inflection analysis, movement speed) that say, “You’re veering toward a depressive state.”
- 1:00:00 – 1:16:00
Are Psychiatric Treatments Any Good? Pills, Talk Therapy, and ECT
Huberman asks whether psychiatry has any reliably effective treatments. Deisseroth affirms that both psychotherapy and medications can be highly effective in many cases, giving examples such as CBT for panic disorder and antipsychotics for schizophrenia. They dig into the trade-offs: powerful medications with serious side effects, and remarkably effective but mechanistically mysterious treatments like electroconvulsive therapy.
- •CBT can be very effective for panic disorder in 6–12 sessions by teaching patients to recognize and derail early panic cues.
- •Antipsychotic drugs can profoundly reduce positive symptoms (hallucinations, paranoia) in schizophrenia but less so negative symptoms (withdrawal, thought blocking).
- •Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia but has the broadest side-effect profile (multi-receptor actions, blood cell risks).
- •ECT is extremely effective for severe, treatment-resistant depression and is now performed safely under anesthesia without overt convulsions.
- •Despite its benefits, ECT is frustratingly nonspecific: a global brain seizure whose antidepressant mechanism remains unknown.
- •Psychiatry lacks the “pump model” cardiology has for the heart; it still needs a unifying, mechanistic framework for many mental disorders.
- 1:16:00 – 1:32:00
Optogenetics: From Algae to Controlling Mammalian Brains
Deisseroth recounts the origin story of channelrhodopsins from 19th-century observations of light-guided algae to modern genetic and optical manipulation in mammals. He explains how channelrhodopsins work at a biophysical level and how his lab solved practical challenges of gene delivery, expression, and light delivery. They discuss how optogenetics evolved from dish experiments to controlling mouse movement and eventually enabling partial vision in a blind human.
- •Russian botanist Andrei Famintsyn observed single-celled algae swim to optimal light levels, revealing light-guided plant behavior.
- •Channelrhodopsins are membrane proteins that open ion channels when hit by photons, depolarizing cells.
- •Neurons also encode information via ion flux, so channelrhodopsins can be used to drive neuron firing with light.
- •Deisseroth’s group had to overcome low conductance (few ions per channel) by safely packing high densities into specific cells and delivering light precisely.
- •By 2007, optogenetics was used to bias mouse behavior (e.g., turning circles) in real time; by 2009, methods were robust across many species.
- •Botond Roska’s work with Deisseroth moved from human cadaver retina to a living blind patient who regained light perception through optogenetic gene therapy plus specialized goggles.
- 1:32:00 – 1:43:00
Indirect Clinical Impact: Using Optogenetics to Design Smarter Treatments
While partial vision restoration is dramatic, Deisseroth stresses that optogenetics’ greatest clinical impact will likely be indirect: using causal circuit mapping to inform all other treatments. They explore how understanding which cells and pathways underlie particular symptoms can guide the development or repurposing of drugs, refine brain stimulation targets, and make psychiatry more like cardiology in its mechanistic specificity.
- •Viral vectors like adeno-associated virus (AAV) safely deliver opsin genes to specific cell types using promoters/enhancers.
- •Ultra–light-sensitive opsins and targeted injection (e.g., nodose ganglion for vagus fibers) make peripheral optogenetic interventions plausible.
- •In principle, specific vagal fibers relevant to mood could be selectively controlled, avoiding side effects seen with electrical vagus nerve stimulation (hoarseness, swallowing/breathing issues).
- •However, we do not yet know exactly which particular projection types (cell from point A to B) drive symptom relief; that knowledge is prerequisite for precise therapies.
- •Deisseroth envisions optogenetics identifying causal-cell populations, then medication development focusing on those cells’ unique receptors/proteins rather than global transmitters.
- •Safer, already-approved drugs might be rapidly repurposed for psychiatric indications once circuit targets are clear.
- 1:43:00 – 2:08:00
Vagus Nerve Stimulation: Crude Tool, Real Patients, Real-Time Tuning
They drill into vagus nerve stimulation (VNS) as an example of both the promise and limitations of current neuromodulation. Deisseroth explains that VNS was chosen largely because the nerve is accessible and projects to brainstem nuclei linked to monoamine systems. He describes how he literally reprograms implant parameters via radio control in his clinic, balancing dose against side effects, and why optogenetic specificity could, in theory, vastly improve such interventions.
- •The vagus nerve was initially targeted for epilepsy largely because it is surgically accessible, then extended to depression.
- •VNS devices consist of a neck cuff electrode connected to a pacemaker-like battery implanted under the clavicle.
- •Stimulating everything in the neck induces side effects: strangulated voice, difficulty swallowing/breathing, limiting how much current can be used.
- •In clinic, Deisseroth interrogates mood over weeks, then slowly raises VNS intensity in-office, monitoring voice and comfort in real time.
- •Therapeutic effects typically emerge over days to weeks, not instantaneously with stimulation changes.
- •Optogenetic VNS would, in principle, allow selective activation of only the relevant fiber types, but requires precise knowledge of which fibers those are.
- 2:08:00 – 2:22:00
Brain–Machine Interfaces, Deep Brain Stimulation, and Circuit-Conscious Psychiatry
Huberman and Deisseroth discuss the broader landscape of brain–machine interfaces (BMI), including Neuralink and long-standing human work with stereo-EEG and deep brain stimulation. Deisseroth sees BMIs as valuable both for discovery and future clinical treatment—especially as closed-loop systems that detect pathological patterns and respond—with their specificity grounded in optogenetic research.
- •Many groups worldwide, including at Stanford, have implanted multi-electrode arrays in humans and non-human primates to record tens of thousands of neurons.
- •BMIs and stereo-EEG in epilepsy patients provide rare opportunities to study human circuits at high resolution.
- •Deep brain stimulation (DBS) with single electrodes can already help refractory OCD and movement disorders like Parkinson’s, even without feedback loops.
- •Closed-loop systems could detect signatures of impending symptoms (like seizures or mood episodes) and trigger targeted stimulation only when needed.
- •Optogenetics is essential for validating that a detected pattern is causal, not just correlative, by recreating it in animals and observing behavior.
- •In the long term, psychiatry will likely incorporate BMIs and DBS alongside refined drugs, all informed by circuit-level understanding.
- 2:22:00 – 2:30:00
ADHD, Tics, and the Role of Modern Environments
ADHD is used as a case study of a diagnosis that straddles trait and environment. Deisseroth outlines the symptom clusters (hyperactive vs. inattentive), diagnostic criteria, and emerging EEG-based tools. Huberman shares personal history of childhood tics and relief from impact sports, raising the question of whether digital lifestyles and phones can create ADHD-like patterns or compulsions.
- •ADHD diagnoses require symptoms across multiple domains (school and home) to ensure they are pervasive, not situational.
- •Subtypes include predominantly inattentive, predominantly hyperactive-impulsive, or combined presentations.
- •Stimulants like Adderall can be highly effective but also controversial regarding overdiagnosis and misuse.
- •Quantitative EEG markers for ADHD are under active investigation and might eventually yield clinic- or home-based tests.
- •Tic disorders share a “build-up and relief” pattern that resembles compulsions; phone-checking may mimic this phenomenology.
- •Psychiatric diagnosis also requires that symptoms impair social or occupational functioning; in today’s context, some phone behaviors are adaptive, complicating pathologization.
- 2:30:00 – 3:07:00
Deisseroth’s Path: From Poetry to Psychiatry and Big Science
Deisseroth traces his personal journey from being obsessed with poetry and language to pursuing neurosurgery, then being transformed by a required psychiatry rotation. He describes how the depth of suffering and mystery in psychiatric patients, combined with the intellectual fascination of altered realities, pulled him into psychiatry and research. He also talks about literary influences like Borges and his use of Spanish, and how those early loves shape his current work.
- •As a youth, he was captivated by poetry’s ability to evoke emotion through rhythm and sound beyond literal meaning.
- •He initially planned to be a neurosurgeon and loved operating-room precision and immediate impact.
- •A mandatory psychiatry rotation exposed him to patients whose experienced reality diverged from his own despite no overt physical lesion, which he found both tragic and scientifically irresistible.
- •He saw psychiatry as the field with the greatest combination of need and mystery—and with enormous potential for scientific progress.
- •Writers like Jorge Luis Borges profoundly influenced his interest in mind, reality, and language.
- 3:07:00 – 3:18:00
CLARITY: Making Brains Transparent to See Their Wiring
They shift to CLARITY and hydrogel tissue chemistry, another transformative technology from Deisseroth’s lab. He explains how embedding tissues in a polymer scaffold and washing out lipids makes entire brains optically transparent while preserving molecules of interest in place. This allows researchers to visualize neuronal architecture in 3D at cellular and subcellular resolution without slicing, opening new possibilities for understanding human and animal brain organization.
- •Hydrogel tissue chemistry builds a polymer ‘jello’ mesh inside all cells of a tissue or whole organ.
- •Proteins, RNAs, and other target molecules are chemically anchored to the hydrogel, then lipids are removed by detergent clearing.
- •The result: entire brains become glass-clear while maintaining the spatial arrangement of molecular markers and fine structures.
- •CLARITY and its variants allow 3D imaging of intact circuits and long-range projections that would be disrupted by slicing.
- •Despite our detailed knowledge of rodent microcircuits, human brain microanatomy remains much less mapped; CLARITY-like methods are critical for closing that gap.
- 3:18:00 – 3:32:00
Dissociation, Ketamine, and Cross-Species Circuit Mapping
Deisseroth describes recent work on dissociation as an example of how optogenetics, human stereo-EEG, and pharmacology converge. Using dissociative anesthetics like ketamine in mice, they identified specific brain regions and activity patterns that correspond to being aware of stimuli but not caring about them. They then matched these patterns in a human epilepsy patient who reported dissociation before seizures, and causally reproduced dissociative-like states in mice by optogenetic replay.
- •Dissociation is common after trauma and in disorders like borderline personality and PTSD; it separates sense of self from bodily experience.
- •Ketamine and PCP are dissociative drugs that produce similar phenomenology, providing an entry point for mechanistic study.
- •In mice, ketamine created conditions where animals detected stimuli but behaviorally ignored them, paralleling human dissociation.
- •Simultaneous neuronal recordings revealed a specific activity pattern in a conserved brain area linked to this behavior.
- •In a human patient with stereo-EEG, similar patterns appeared in the homologous region during pre-seizure dissociative episodes.
- •Optogenetic induction of that pattern in mice was sufficient to induce a dissociative-like behavioral state, completing the causal loop.
- 3:32:00 – 3:51:00
Psychedelics, MDMA, and How Altered States Might Heal
They broaden from ketamine to psychedelics and MDMA as therapeutic tools. Deisseroth frames the cortex as a model-building system that normally filters out most speculative hypotheses before they reach consciousness. Psychedelics seem to relax that filter, letting unusual models into awareness, which may be harmful in extremes but potentially liberating for rigid, depressive thought patterns. MDMA’s unique combination of dopamine and serotonin flooding may teach new interpersonal possibilities, particularly in trauma therapy.
- •Psychedelics alter the experience of reality in relatively specific ways but can be addictive and destabilizing if misused.
- •In depression, patients are stuck in models where their actions and the world’s responses feel valueless and futureless.
- •Psychedelics may allow new “tendrils” of thought about the future to escape and be tested, expanding perceived possibility space.
- •MDMA releases large amounts of serotonin and dopamine, producing intense connection and reduced fear; after the drug wears off, the brain retains learning that such states are possible.
- •This learned potential for connection can be harnessed in PTSD and trauma therapy, but must be managed rigorously to avoid lasting harm.
- •Deisseroth is actively studying psychedelics in tightly regulated lab settings to determine how they alter circuit-level representations of paths into the future.
- 3:51:00 – 4:18:00
Structuring a Life of Science, Clinics, Family, and Writing
The final substantive segment turns inward to how Deisseroth manages his cognitive resources and time. He emphasizes structuring each day around at least an hour of uninterrupted, motionless thinking, often with an internal verbal monologue. During book-writing, he added midnight writing blocks and obsessively refined sentence rhythm and word choice. He sees focused introspection as both a trainable skill and a necessity for high-level intellectual work, while acknowledging that life must often be taken a day at a time.
- •Deisseroth leads a 40+ person lab, maintains a psychiatry clinic, raises five children, and writes, so he focuses on the unit of the day.
- •He protects at least one hour per day for pure thinking: sitting very still, eyes open, no phone, often in a quasi-meditative state.
- •He is a highly verbal thinker; reasoning occurs as internal sentences with attention to rhythm and cadence.
- •During *Projections*, he used extra midnight–2 a.m. blocks and sometimes spent days on a single word, discarding near-perfect passages that weren’t quite right.
- •Different children display different modalities (musical, visual, physical), but all share some appreciation for language.
- •He aimed in his book to be accessible to everyone while remaining scientifically rigorous enough that no colleague could say he’d overstated the data.
- 4:18:00
Closing Notes: Optimism, Projections, and Supporting Science
Huberman and Deisseroth wrap up by reaffirming optimism about the trajectory of psychiatry given current tools and discoveries. Huberman endorses *Projections* as both scientifically rigorous and beautifully written, and they briefly mention ways for listeners to follow Deisseroth or support the podcast. Huberman reiterates his mission of sharing science-based tools with the public at zero cost.
- •Deisseroth identifies as an optimist; he believes the trajectory of understanding and treating mental illness is “beautiful,” though incomplete.
- •*Projections* is framed as a bridge between the lay public and cutting-edge neuroscience and psychiatry.
- •Deisseroth uses Twitter as his main public communication channel.
- •Huberman encourages listeners to read the book, subscribe to the podcast, and support via sponsors or Patreon.
- •The episode is positioned as a foundation for future explorations of nervous system function and dysfunction on the podcast.
